[2021] Roxithromycin Market Size and Share to Project Lucrative CAGR By 2026 | Future Growth Trends, Key Players Profile, Business Insights, Overview, Growth Projection and Global Market Analysis By 2026

SEATTLE, April 12, 2021, (PHARMIWEB) — Roxithromycin, which is also referred to as arrow-roxithromycin, is a semi-synthetic macrolide antibiotic, which is used to prevent bacterial growth. The drug is basically used to treat certain types of bacterial infections such as sinusitis, pharyngitis, bronchitis and pneumonia, urinary and soft tissue infections, and otitis media.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/2257

Market– Driver

Growing research activities for expanding applications of roxithromycin is projected to fuel the growth of the roxithromycin market over the forecast period. For instance, according to research by Otago University, New Zealand in July 2018, roxithromycin can be effective in treating myeloma, a cancer of plasma cells that usually arises in the bone marrow and is mainly associated with depletion of hemoglobin levels. The drug enhances hemoglobin levels. However, the drug is still under research to confirm its application in treating myeloma.

Restraint

Drug recalls due to lack of quality standards are projected to hinder the growth of the market. For instance, in July 2016, the Ministry of Health, Vietnam recalled Rom-150 tablets (Roxithromycin 150mg) manufactured by Zee Laboratories and imported by Codupha Central Pharmaceutical JSC in Vietnam. The decision to recall these drugs was based on tests performed by the National Institute of Drug Quality Control.

Regional Analysis

On the basis of region, the global roxithromycin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is projected to hold a dominant position in the global roxithromycin market during the forecast period and this can be attributed to rising government initiatives to prevent antimicrobial resistance and rising awareness regarding the proper use of antibiotics. For instance, in March 2015, Health Canada released Federal Action Plan with rules to reduce the risk of antimicrobial resistance in Canada, which includes infection prevention and control, research and innovation in developing antibiotics, and appropriate antimicrobial use for health professionals and the public of Canada.

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2257

The Asia Pacific is projected to experience significant growth in the global roxithromycin market over the forecast period due to high infectious disease burden, unregulated sales of antibiotics and poor public health infrastructure. For instance, according to a report published in the journal The Lancet Infectious Diseases February 2017, Low-Income and Middle-Income Countries (LMICs) of the Asia Pacific such as Nepal, Pakistan, India, and Bangladesh witness significant demand for roxithromycin, due to less strict policies and easy availability of antibiotics over the counter.

Key players operating in the global roxithromycin market include Hetero Healthcare Ltd., Finecure Pharmaceuticals Ltd., Zhejiang Zhenyuan Pharmaceutical Co Ltd, Johnson & Johnson Private Limited, Hygeia Laboratories Inc, Bayer AG, Allergan plc. Galderma S.A, Valeant Pharmaceutical International, and Stiefel Laboratories

Market– Taxonomy

By Indication

• Urinary and Soft Tissue Infections
• Respiratory Tract Infections
• Pneumonia
• Otitis media
• Sinusitis

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837